Targeted lung denervation (TLD) with the Ryme Medical Lung Denervation System in patients with chronic obstructive pulmonary disease (COPD) - Ryme Medical TLD Pilot Study
The study is a prospective, multi-center, non-randomized study to evaluate the safety and performance of the Ryme Medical Lung Denervation System in patients with chronic obstructive pulmonary disease (COPD)
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Targeted Lung Denervation (TLD) is a bronchoscopically guided, minimally invasive procedure using the Ryme Medical Lung Denervation System
Melbourne Health - The Royal Melbourne Hospital
Melbourne, Australia
Macquarie University
Sydney, Australia
Karl Landsteiner Institute for Lung Research
Vienna, Austria
Rigshospitalet
Copenhagen, Denmark
Device Safety
Serious adverse events associated with the Ryme Medical Lung Denervation System
Time frame: 30 Days
Device Success
Time frame: Day 0
Technical Success
Time frame: Day 0
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Healthycore
Tbilisi, Georgia
University of Groningen Medical Center
Groningen, Netherlands
Royal Brompton
London, United Kingdom